Action Merus NV - MRUS

Merus NV (MRUS) Action

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Dernier

90,00

( - )

Prix Achat

89,01

Prix Vente

88,00

Volume échangé

0,00 Fourchette du Jour 0,00

0,00 Plage de 52 semaines 0,00

Clôture Veille

90,00

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume moyen (3 m)

Volume financier

VWAP

Form 8-K - Current report

Form SC 14D9/A - Solicitation, recommendation statements: [Amend]

Form SC TO-T/A - Tender offer statement by Third Party: [Amend]

Immunotherapy Breakthroughs Turn Cold GI Tumors Hot as Market Tops $443B

Immunotherapy Breakthroughs Turn Cold GI Tumors Hot as Market Tops $443B PR Newswire VANCOUVER, BC, Dec...

Form 4 - Statement of changes in beneficial ownership of securities

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

MRUS - Frequently Asked Questions (FAQ)

What is the current Merus NV share price?

The current share price of Merus NV is US$ 90,00

What is the 1 year trading range for Merus NV share price?

Merus NV has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Merus NV (MRUS)

Merus NV (MRUS) Action

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

MRUS Dernières nouvelles

Form 8-K - Current report

Form SC 14D9/A - Solicitation, recommendation statements: [Amend]

Form SC TO-T/A - Tender offer statement by Third Party: [Amend]

Immunotherapy Breakthroughs Turn Cold GI Tumors Hot as Market Tops $443B

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form 8-K - Current report

Form SC 14D9/A - Solicitation, recommendation statements: [Amend]

Form SC TO-T/A - Tender offer statement by Third Party: [Amend]

Immunotherapy Breakthroughs Turn Cold GI Tumors Hot as Market Tops $443B

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

MRUS - Frequently Asked Questions (FAQ)

MRUS Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Merus NV (MRUS)

Merus NV (MRUS) Action

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

MRUS Dernières nouvelles

Form 8-K - Current report

Form SC 14D9/A - Solicitation, recommendation statements: [Amend]

Form SC TO-T/A - Tender offer statement by Third Party: [Amend]

Immunotherapy Breakthroughs Turn Cold GI Tumors Hot as Market Tops $443B

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form 8-K - Current report

Form SC 14D9/A - Solicitation, recommendation statements: [Amend]

Form SC TO-T/A - Tender offer statement by Third Party: [Amend]

Immunotherapy Breakthroughs Turn Cold GI Tumors Hot as Market Tops $443B

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

MRUS - Frequently Asked Questions (FAQ)

MRUS Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Inscrivez-vous GRATUITEMENT et obtenez:

Supprimer les publicités

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS